The present invention relates to a method for treating a patient having
suffered from severe aphasia associated with cerebrovascular accident
chronic stage for at least three years, wherein said treatment consists
essentially of administering a composition comprising
2-oxo-1-pyrrolidineacetamide as an active ingredient and a
pharmaceutically acceptable carrier.